MX379066B - Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. - Google Patents

Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.

Info

Publication number
MX379066B
MX379066B MX2015003110A MX2015003110A MX379066B MX 379066 B MX379066 B MX 379066B MX 2015003110 A MX2015003110 A MX 2015003110A MX 2015003110 A MX2015003110 A MX 2015003110A MX 379066 B MX379066 B MX 379066B
Authority
MX
Mexico
Prior art keywords
bladder
treatment
methods
drug delivery
voidious
Prior art date
Application number
MX2015003110A
Other languages
English (en)
Other versions
MX2015003110A (es
Inventor
Dennis Giesing
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Publication of MX2015003110A publication Critical patent/MX2015003110A/es
Publication of MX379066B publication Critical patent/MX379066B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)

Abstract

Se proporcionan métodos, dispositivos y medicamentos que incluyen trospio para el uso en el tratamiento de disfunción vesical mediante la administración local de trospio a la vejiga para lograr una concentración sostenida de trospio en la orina en la vejiga suficiente para producir una concentración terapéutica de trospio en el tejido de la vejiga. El fármaco se puede administrar a la vejiga desde un dispositivo de administración de fármaco intravesical insertado a la vejiga, donde el dispositivo libera continuamente el fármaco a la orina en la vejiga por un período extendido de horas o días.
MX2015003110A 2012-09-18 2013-09-18 Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. MX379066B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261702576P 2012-09-18 2012-09-18
PCT/US2013/060479 WO2014047221A1 (en) 2012-09-18 2013-09-18 Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium

Publications (2)

Publication Number Publication Date
MX2015003110A MX2015003110A (es) 2015-06-05
MX379066B true MX379066B (es) 2025-03-04

Family

ID=49301639

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015003110A MX379066B (es) 2012-09-18 2013-09-18 Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.
MX2020002465A MX2020002465A (es) 2012-09-18 2015-03-11 Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros transtornos del tracto urinario inferior.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020002465A MX2020002465A (es) 2012-09-18 2015-03-11 Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros transtornos del tracto urinario inferior.

Country Status (13)

Country Link
US (2) US10500200B2 (es)
EP (1) EP2897616A1 (es)
JP (2) JP6600256B2 (es)
KR (1) KR102141433B1 (es)
CN (2) CN104684556A (es)
AU (1) AU2013318146B2 (es)
BR (1) BR112015005351A2 (es)
CA (1) CA2883855C (es)
IL (1) IL237498B (es)
MX (2) MX379066B (es)
RU (1) RU2670749C9 (es)
SG (1) SG11201502104YA (es)
WO (1) WO2014047221A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8721621B2 (en) 2009-09-10 2014-05-13 Taris Biomedical, Inc. Systems and methods for deploying devices to genitourinary sites
CA2882575C (en) 2012-08-31 2020-05-26 Dennis GIESING Drug delivery systems and methods for treatment of prostate
HRP20211921T1 (hr) 2012-08-31 2022-03-04 Taris Biomedical Llc Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s oksaliplatinom
AU2013318146B2 (en) * 2012-09-18 2018-05-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium
JP6691715B2 (ja) * 2014-08-19 2020-05-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 局所的薬物送達のためのインプラント及びその使用
GB201506526D0 (en) 2015-04-17 2015-06-03 Uropharma Ltd And Synesis Llc Medicinal composition
CN106706832A (zh) * 2015-08-06 2017-05-24 舒泰神（北京）生物制药股份有限公司 一种测定曲司氯铵含量的方法
US11020575B2 (en) 2017-02-01 2021-06-01 Taris Biomedical Llc In vivo drug delivery devices and methods for drug delivery
SG10201913998YA (en) 2017-07-25 2020-03-30 Taris Biomedical Llc Methods of treating tumor metastasis
TWI841554B (zh) 2018-03-21 2024-05-11 丹麥商珍美寶股份有限公司 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法
CA3099547A1 (en) 2018-05-07 2019-11-14 Reshma Abdulla RANGWALA Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate
JP2021532155A (ja) * 2018-08-01 2021-11-25 タリス バイオメディカル エルエルシー トロスピウムを使用した過活動膀胱の治療方法
TWI844571B (zh) 2018-10-30 2024-06-11 丹麥商珍美寶股份有限公司 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法
WO2020222139A1 (en) * 2019-04-30 2020-11-05 Trigone Pharma Ltd. Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
US12576063B2 (en) 2020-03-20 2026-03-17 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
KR102596697B1 (ko) 2021-05-20 2023-11-01 김정우 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물 및 그 제조 방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172117T1 (de) * 1996-11-27 1998-10-15 Pfleger R Chem Fab Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
AU2003286129A1 (en) * 2002-12-11 2004-06-30 Coloplast A/S A urinary catheter device with a pharmaceutically active composition
US8481518B2 (en) 2003-01-16 2013-07-09 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
DE602004020337D1 (de) 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
WO2006101954A2 (en) * 2005-03-17 2006-09-28 Indevus Pharmaceuticals, Inc. Interstitial cystitis treatment
US7390816B2 (en) 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
EP1933810B1 (en) 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
EP1967202A1 (en) 2007-03-05 2008-09-10 AEterna Zentaris GmbH Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity
JP5560200B2 (ja) * 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
CN102176931B (zh) 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8721621B2 (en) 2009-09-10 2014-05-13 Taris Biomedical, Inc. Systems and methods for deploying devices to genitourinary sites
SI2512581T1 (sl) 2009-12-17 2021-09-30 Taris Biomedical Llc Vsadljiva naprava z intravezikalno sprejemljivostjo
US20110218488A1 (en) 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
US9457176B2 (en) 2010-10-06 2016-10-04 Taris Biomedical Llc Implantable drug delivery device with bladder retention feature
WO2012048114A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Time-selective bioresorbable or collapsible drug delivery systems and methods
SG191893A1 (en) 2011-01-10 2013-08-30 Taris Biomedical Inc Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
RU2598057C2 (ru) * 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
AU2013318146B2 (en) * 2012-09-18 2018-05-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium
SG11201507294WA (en) 2013-03-15 2015-10-29 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods

Also Published As

Publication number Publication date
KR20150058271A (ko) 2015-05-28
IL237498A0 (en) 2015-04-30
CN111450093A (zh) 2020-07-28
JP2015529688A (ja) 2015-10-08
MX2020002465A (es) 2020-07-13
WO2014047221A9 (en) 2015-05-21
MX2015003110A (es) 2015-06-05
RU2670749C2 (ru) 2018-10-25
CA2883855A1 (en) 2014-03-27
CA2883855C (en) 2020-09-15
RU2015112196A (ru) 2016-11-10
WO2014047221A1 (en) 2014-03-27
SG11201502104YA (en) 2015-05-28
IL237498B (en) 2018-01-31
US10500200B2 (en) 2019-12-10
BR112015005351A2 (pt) 2017-07-04
CN104684556A (zh) 2015-06-03
KR102141433B1 (ko) 2020-08-05
US11850244B2 (en) 2023-12-26
EP2897616A1 (en) 2015-07-29
RU2670749C9 (ru) 2018-12-13
JP2018080208A (ja) 2018-05-24
AU2013318146A1 (en) 2015-03-19
US20150182516A1 (en) 2015-07-02
AU2013318146B2 (en) 2018-05-10
JP6600256B2 (ja) 2019-10-30
US20200108057A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
MX379066B (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.
MX367070B (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata.
CY1124890T1 (el) Συστηματα και μεθοδοι χορηγησης φαρμακων για θεραπεια καρκινου της ουροδοχου κυστης που περιλαμβανουν οξαλιπλατινη
MX2016011333A (es) Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina.
WO2014197632A3 (en) Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract
WO2012002760A3 (ko) 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법
NZ630213A (en) Methods of treating bladder cancer
EP4461326A3 (en) Flexible system for delivering an anchor
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
WO2013085901A3 (en) Systems and methods for delivery of a medical device
EP3300734A3 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
MX2019003173A (es) Terapia de combinacion con agonistas de peptido natriuretico tipo c (cnp) de liberacion controlada.
MY193694A (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
GB201111485D0 (en) Drug composition and its use in therapy
MX352824B (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
WO2012023623A3 (ja) ハンター症候群の治療剤
MX2014000777A (es) Cateter, en particular cateter permanente para el tratamiento de disfunciones y/o enfermedades de la vejiga y/o la prostata.
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
EA032959B9 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
Barsotti CMV lung infection, bladder infection and erythematous rash: 3 case reports
WO2011028800A3 (en) Treatment of cognitive dysfunction with gangliosides
UA69982U (ru) Способ лечения рецидивирующей формы герпетической инфекции
RU2010124455A (ru) Способ лечения пострадавших с сочетанной черепно-мозговой травмой